Results 51 to 60 of about 72,557 (166)

Network of nanomedicine researches: impact of Iranian scientists [PDF]

BioImpacts, 2015
Introduction: We may define the nanomedicine as the use of nanotechnology in the health care, disease diagnoses and treatment in order to maintain and increase the health status of a population through improve pharmacotherapy.
Mohammad-Hossein Biglu, Shukuh Riazi
doaj   +1 more source

Exploiting Endocytosis for Nanomedicines [PDF]

Cold Spring Harbor Perspectives in Biology, 2013
In this article, we briefly review the endocytic pathways used by cells, pointing out their defining characteristics and highlighting physical limitations that may direct the internalization of nanoparticles to a subset of these pathways. A more detailed description of these pathways is presented in the literature.
Akinc, A., Battaglia, G.
openaire   +2 more sources

Photocatalytic Degradation of Cephalexin, Amoxicillin, and Phenol Red Using a Green-Synthesized Folic Acid–ZnO–Bi2O3 Nanoporous System

International Journal of Photoenergy
The persistent presence of pharmaceutical pollutants like amoxicillin (AMX) and cephalexin (CPX), and industrial dyes such as phenol red (PR) in wastewater poses serious ecological and public health risks, including antibiotic resistance. It necessitates
M. Sarani, H. Haghighi, P. Tamaddon, A. Najafidoust, P. Faghani-Eskandarkolaei, N. Sattarahmady   +5 more
doaj   +1 more source

Rapid and scalable detection of synthetic mRNA byproducts using polynucleotide phosphorylase and polythymidine oligonucleotides

RNA Biology
Production and storage of synthetic mRNA can introduce a variety of byproducts which reduce the overall integrity and functionality of mRNA vaccines and therapeutics.
Francis Combes, Thanh-Huong Bui, Frida J. Pettersson, Sjoerd Hak   +3 more
doaj   +1 more source

Machine Learning‐Driven Prediction, Preparation, and Evaluation of Functional Nanomedicines Via Drug–Drug Self‐Assembly

Advanced Science
Small molecules as nanomedicine carriers offer advantages in drug loading and preparation. Selecting effective small molecules for stable nanomedicines is challenging.
Chengyuan Zhang, Yuchuan Yuan, Qiong Xia, Junjie Wang, Kangkang Xu, Zhiwei Gong, Jie Lou, Gen Li, Lu Wang, Li Zhou, Zhirui Liu, Kui Luo, Xing Zhou   +12 more
doaj   +1 more source

Multifunctional Applications of Extracellular Nanovesicles for Acute Kidney Injury and Renal Fibrosis; a Mini Review

International Journal of Nanomedicine
Ruizhe Xu,1 Shuainan Liu,2 Zhenhua Cui1 1Department of Nephrology, College of Medicine, Yanbian University, Yanji, Jilin, 133000, People’s Republic of China; 2Department of Dermatology, College of Medicine, Yanbian University, Yanji, Jilin, 133000 ...
Xu R, Liu S, Cui Z
doaj  

Introduction to Nanomedicine [PDF]

Molecules, 2015
Although mentions of nanoparticles in relation to biomedicine appeared in the late 1970s and are now the subject of over 10,000 publications per year, the term “Nanomedicine” only appeared at the turn of this century, and less than 30 papers including this term were published up to 2005. [...]
openaire   +3 more sources

Nanomedicine in glaucoma treatment; Current challenges and future perspectives

Materials Today Bio
Glaucoma presents a significant global health concern and affects millions of individuals worldwide and predicted a high increase in prevalence of about 111 million by 2040.
Haroon Iqbal, Anam Razzaq, Dengming Zhou, Jiangtao Lou, Run Xiao, Fu Lin, Yuanbo Liang   +6 more
doaj   +1 more source

La science en action ? Luttes d’expansion institutionnelle à l’exemple de la nanomédecine en Allemagne

Terminal, 2016
Where is nanomedicine developed in Germany, and which are the German scientific institutions working in this field ? On the Internet, there is a rich documentation about nanotechnologies, as well as about nanomedicine. According to the philosophy of Open
Christian Papilloud
doaj   +1 more source

A novel pH-sensitive nanoparticles encapsulating anti-PD-1 antibody and MDK-siRNA overcome immune checkpoint blockade resistance in HCC via reshaping immunosuppressive TME

Journal of Experimental & Clinical Cancer Research
Objective Immunotherapy, notably the immune checkpoint blockade (ICB), has demonstrated significant promise in the management of diverse neoplasms. However, the PD-1 inhibitor has exhibited suboptimal objective response rates and did not achieve the ...
Hai Xu, Shuo Li, Yifan Liu, Yoon-Young Sung, Yong Zhou, Huikun Wu   +5 more
doaj   +1 more source